Similar articles

• Reversal of neurologic deficits in Down syndrome.

  Schinitsy MR. Schinitsy MR. Am J Dis Child. 1992 Jul;146(7):783. Am J Dis Child. 1992. PMID: 1386709 No abstract available.
• Cardiovascular and autonomic function in Down syndrome--prescribing implications.

  Carpenter PK. Carpenter PK. Br J Psychiatry. 1995 Jul;167(1):118-9. doi: 10.1192/bjp.167.1.118b. Br J Psychiatry. 1995. PMID: 7551603 No abstract available.
• Medical management of the adult patient with Down syndrome.

  Galley R. Galley R. JAAPA. 2005 Apr;18(4):45-6, 48, 51-2. doi: 10.1097/01720610-200504000-00006. JAAPA. 2005. PMID: 15859488 Review.
• Pretreatment systolic orthostatic blood pressure depression in Down's syndrome.

  Pary RJ. Pary RJ. J Clin Psychopharmacol. 1989 Apr;9(2):146-7. doi: 10.1097/00004714-198904000-00021. J Clin Psychopharmacol. 1989. PMID: 2524507 No abstract available.
• Pharmacological interventions to improve cognition and adaptive functioning in Down syndrome: Strides to date.

  Hart SJ, Visootsak J, Tamburri P, Phuong P, Baumer N, Hernandez MC, Skotko BG, Ochoa-Lubinoff C, Liogier D'Ardhuy X, Kishnani PS, Spiridigliozzi GA. Hart SJ, et al. Am J Med Genet A. 2017 Nov;173(11):3029-3041. doi: 10.1002/ajmg.a.38465. Epub 2017 Sep 8. Am J Med Genet A. 2017. PMID: 28884975 Review.